Approval is only the beginning. Now comes the harder part: identifying the right patients, detecting the disease earlier, and monitoring outcomes so that this promising treatment is effective at scale.
The post After Wegovy’s Historic MASH Approval, What’s Next? appeared first on MedCity News.
